Name Development Level Target Family
Vascular endothelial growth factor A Tclin Non-IDG
Vascular endothelial growth factor B Tclin Non-IDG
Placenta growth factor Tclin Non-IDG
Glucocorticoid receptor Tclin Nuclear Receptor
Name Description
aflibercept consists of the second and third Ig domains of VEGFR1 and VEGFR2, respectively, fusion to the Fc region of IgG1; putative antineoplastic agent that binds all VEGF-A isoforms; possible medicine for eye disorders
TCRDv4.6.0
DrugCentral Indication
DrugCentral
aflibercept